特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
599602

世界の結核診断および治療市場調査と予測

Global Tuberculosis Diagnosis and Treatment Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.58円
世界の結核診断および治療市場調査と予測
出版日: 2019年10月10日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の結核診断および治療市場について調査し、市場の規模と薬剤別、診断別、エンドユーザー別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 レポートのサマリー

第2章 市場概要と動向

  • 定義
  • アナリストの見解および現在の市場動向
  • 法規制

第3章 市場決定因子

  • 促進因子
  • 阻害因子
  • 機会

第4章 市場セグメンテーション

  • 薬剤別
    • 第一次薬剤
    • 第二次薬剤
    • 非合理滴デザイン
  • 診断別
    • 試験所検査
    • 核酸検査
    • ツベルクリン反応
    • ラジオグラフィー
    • 薬剤感受性検査
    • その他
  • エンドユーザー別
    • 病院
    • 政府機関
    • 個人
    • その他

第5章 競合環境

  • 主な戦略
  • 主要企業分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 企業プロファイル

  • ABBOTT LABORATORIES
  • AKONNI BIOSYSTEMS, INC.
  • ALERE, INC.
  • BECTON DICKINSON AND CO.
  • BIO - SYNTH INC.
  • BIOMERIEUX SA
  • CEPHEID INC
  • EIKEN CHEMICAL CO. LTD.
  • EPISTEM HOLDINGS PLC
  • F. HOFFMANN-LA ROCHE AG
  • HAIN LIFESCIENCES GMBH
  • HOLOGIC CORPORATION
  • GLAXOSMITHKLINE
  • LABATEC PHARMA SA
  • LUPIN
  • OTSUKA NOVEL PRODUCTS GMBH
  • QIAGEN
  • SANDOZ
  • SANOFI
  • THERMO FISHER SCIENTIFIC, INC
図表

LIST OF TABLES

  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • GLOBAL LABORATORY TESTINGFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL NUCLEIC ACID TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL RADIOGRAPHYFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL DRUG SUSCEPTIBILITY TESTFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • GLOBAL FIRST LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL SECOND LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • GLOBAL HOSPITALS& CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL GOVERNMENT & NON-GOVERNMENT ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • EUROPEANTUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • ASIA-PACIFICTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • GLOBAL LABORATORY TESTINGFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL NUCLEIC ACID TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL RADIOGRAPHYFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL DRUG SUSCEPTIBILITY TESTFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER TESTSFOR TUBERCULOSIS DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • GLOBAL FIRST LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL SECOND LINE DRUGSFOR TUBERCULOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • GLOBAL HOSPITALS& CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL GOVERNMENT & NON-GOVERNMENT ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • NORTH AMERICANTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • NORTH AMERICAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • EUROPEANTUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • EUROPEAN TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • ASIA-PACIFICTUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS, 2018-2025 ($ MILLION)
  • REST OF THE WORLD TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019918

Title:
Global Tuberculosis Diagnosis and Treatment
Market Size, Share & Trends Analysis Report, By Diagnosis (Laboratory Testing, Nucleic Acid Tests, Radiography, Drug Susceptibility Test, and Other Tests),B Drugs (First Line Drugs and Second Line Drugs), By End-User (Hospitals & Clinics, Government & Non-Government Organizations, and Others), and Forecast 2019-2025.

The global tuberculosis diagnosis and treatment market is expected to grow at a significant rate during 2019-2025. Tuberculosis is one of the top 10 causes of global fatalities as it affects the lungs and causes life-threatening conditions in the human body. The market growth is attributed to the rising incidence of drug-susceptible (DS) tuberculosis (TB), an increase in multi-drug resistant (MDR) TB cases and increasing R&D for the development of tuberculosis drugs. In addition, robust product pipeline for the tuberculosis products and increasing initiatives by the government in emerging economies for the treatment of tuberculosis creates an ample opportunity for the growth of the market in the near future.

The global tuberculosis diagnosis and treatment market are segmented on the basis of diagnosis, drugs, and end-user. Based on the diagnosis, the market is segmented into laboratory testing, nucleic acid tests, radiography, drug susceptibility test, and other tests. Laboratory testing for tuberculosis diagnosis is expected to hold a significant share in the market owing to advancements in culture-based tests. Further, on the basis of drugs, the market is bifurcated into first-line drugs such as Pyrazinamide (Z/PZA), Ethambutol (E/EMB), Rifabutin (RFB), and Streptomycin; and second-line drugs such as Kanamycin (KM), Amikacin (AMK), and Capreomycin (CM). Based on the end-user, the market is segmented into hospitals & clinics, government & non-government organizations, and others. Hospitals & clinics are expected to contribute a major share in the market.

Geographically, the market study of the global tuberculosis diagnosis and treatment market report covers the analysis of four major region including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of the World (RoW). Increasing prevalence of tuberculosis across the globe is expected to give a boost to the growth of the market. Further, the market study covers the analysis of several players operating in the market. Some of the key players operating in the market include Abbott Laboratories, Inc., F. Hoffmann La Roche AG, Beckton, Dickinson, and Co., Otsuka Pharmaceuticals Co. Ltd., Johnson & Johnson Services, Inc., and Novartis AG.

Research Methodology

The market study of the global tuberculosis diagnosis and treatment is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for tuberculosis drug manufacturers, suppliers, traders, and third-party distributors, pharmaceutical contract manufacturers, medical device companies, investing companies and potential investors, government organizations and research institutes, regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and market growth opportunities. The report will serve as a source for a 360-degree analysis of the market delivering insights into the market for making better business decisions.

Market Segmentation

  • 1. Global Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis.
  • 2. Global Tuberculosis Diagnosis and Treatment Market Research and Analysis by Drugs.
  • 3. Global Tuberculosis Diagnosis and Treatment Market Research and Analysis by End-User.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Otsuka Pharmaceuticals Co. Ltd.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Johnson & Johnson Services Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Abbott Laboratories, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Becton, Dickinson and Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Thermo Fisher Scientific, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Tuberculosis Diagnosis and Treatment Market by Diagnosis
    • 5.1.1. Laboratory Testing
    • 5.1.2. Nucleic Acid Tests
    • 5.1.3. Radiography
    • 5.1.4. Drug Susceptibility Test
    • 5.1.5. Other Tests
  • 5.2. Global Tuberculosis Diagnosis and Treatment Market by Drugs
    • 5.2.1. First Line Drugs
    • 5.2.2. Second Line Drugs
  • 5.3. Global Tuberculosis Diagnosis and Treatment Market by End-User
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Government & Non-Government Organizations
    • 5.3.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Akonni Biosystems, Inc.
  • 7.3. Alere, Inc.
  • 7.4. Becton Dickinson and Co.
  • 7.5. Biochemical and Synthetic Products Pvt Ltd
  • 7.6. Biomerieux SA
  • 7.7. Cepheid Inc.
  • 7.8. Eiken Chemical Co. Ltd.
  • 7.9. Epistem Ltd.
  • 7.10. F. Hoffmann-LA Roche AG
  • 7.11. GlaxoSmithKline PLC
  • 7.12. Hain Lifescience GmbH
  • 7.13. Hologic Inc.
  • 7.14. Johnson & Johnson Services, Inc.
  • 7.15. Labatec Pharma SA
  • 7.16. Lupin Pharmaceuticals Inc.
  • 7.17. Novartis AG
  • 7.18. Otsuka Pharmaceutical Co. Ltd.
  • 7.19. PerkinElmer Inc.
  • 7.20. Qiagen GmbH
  • 7.21. Sanofi SA

Thermo Fisher Scientific, Inc.

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.